Calcium carbonate 750 MG / simethicone 250 MG Chewable Tablet [Gas-X Total Relief] — RxCUI 2590817
RxNorm drug concept · Semantic branded drug
RxCUI 2590817
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2590817
Official nameCalcium carbonate 750 MG / simethicone 250 MG Chewable Tablet [Gas-X Total Relief]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asGas-X Total Relief 750 MG / 250 MG Chewable Tablet
FDA products mapped2
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Calcium Carbonate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Most people use it as a fast-acting antacid to get quick relief from heartburn, acid indigestion, sour stomach, or an upset stomach. You'll find it in brands like Tums, Rolaids, an...
- What is calcium carbonate actually used for?
- Don't use the maximum daily dose for more than 2 weeks in a row without talking to a doctor first. If your heartburn or stomach symptoms keep coming back or don't improve, that's y...
- How long can I keep taking this before I should see a doctor?
🕸️ Concept Web — How Calcium carbonate 750 MG / simethicone 250 MG Ch... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Calcium carbonate 750 MG / simethicone 250 MG Chewable Tablet [Gas-X Total Relief]
RxCUI 2590817 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Calcium carbonate
1897IN -
Simethicone
9796IN -
Calcium carbonate / simethicone
645048MIN
-
Calcium carbonate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Gas-X Total Relief
2590811BN
-
Gas-X Total Relief
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Calcium carbonate / simethicone Chewable Tablet
371210SCDF -
Calcium carbonate / simethicone Chewable Product
1295638SCDG -
Calcium carbonate / simethicone Oral Product
1153841SCDG -
Calcium carbonate / simethicone Pill
1153842SCDG -
Calcium carbonate / simethicone Chewable Tablet [Gas-X Total Relief]
2590816SBDF -
Gas-X Total Relief Chewable Product
2590815SBDG -
Gas-X Total Relief Oral Product
2590813SBDG -
Gas-X Total Relief Pill
2590814SBDG - +4 more in this family
-
Calcium carbonate / simethicone Chewable Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Calcium carbonate 750 MG / simethicone 250 MG Chewable Tablet
1741562SCD -
Calcium carbonate 750 MG
315543SCDC -
Simethicone 250 MG
337310SCDC -
Calcium carbonate 750 MG / simethicone 250 MG [Gas-X Total Relief]
2590812SBDC
-
Calcium carbonate 750 MG / simethicone 250 MG Chewable Tablet
Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Calcium carbonate 750 MG / simethicone 250 MG Chewable Tablet
SCD · 1741562 -
Calcium carbonate 750 MG
SCDC · 315543 -
Simethicone 250 MG
SCDC · 337310 -
Calcium carbonate / simethicone Chewable Tablet
SCDF · 371210 -
Calcium carbonate / simethicone Chewable Product
SCDG · 1295638 -
Calcium carbonate / simethicone Oral Product
SCDG · 1153841 -
Calcium carbonate / simethicone Pill
SCDG · 1153842
Brand-Name Concepts
-
Calcium carbonate 750 MG / simethicone 250 MG [Gas-X Total Relief]
SBDC · 2590812 -
Calcium carbonate / simethicone Chewable Tablet [Gas-X Total Relief]
SBDF · 2590816 -
Gas-X Total Relief Chewable Product
SBDG · 2590815 -
Gas-X Total Relief Oral Product
SBDG · 2590813 -
Gas-X Total Relief Pill
SBDG · 2590814 -
Gas-X Total Relief
BN · 2590811
📦 FDA Products & Package NDCs
2 products · 4 package NDCs
4 package NDCs map to RxCUI 2590817 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00067-0118-01 | 10 TABLET, CHEWABLE in 1 POUCH (0067-0118-01) | Gas-X Total Relief Maximum Strength | Haleon US Holdings LLC | 2022-02-03 |
| 00067-0118-02 | 1 BOTTLE in 1 CARTON (0067-0118-02) / 65 TABLET, CHEWABLE i... | Gas-X Total Relief Maximum Strength | Haleon US Holdings LLC | 2022-02-03 |
| 00067-0118-03 | 1 BOTTLE in 1 CARTON (0067-0118-03) / 30 TABLET, CHEWABLE i... | Gas-X Total Relief Maximum Strength | Haleon US Holdings LLC | 2022-02-03 |
| 00067-0119-01 | 2 TABLET, CHEWABLE in 1 POUCH (0067-0119-01) | Gas-X Total Relief Maximum Strength | Haleon US Holdings LLC | 2022-02-03 |
Observed labelers:
Haleon US Holdings LLC (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.